The Efficacy of Shielding Systems for Reducing Operator Exposure during Neurointerventional Procedures: A Real-World Prospective Study

被引:2
|
作者
Miller, T. R. [1 ,2 ]
Zhuo, J. [1 ,2 ]
Jindal, G. [1 ,2 ]
Shivashankar, R. [1 ,2 ]
Beaty, N. [3 ]
Gandhi, D. [1 ,2 ]
机构
[1] Univ Maryland, Med Ctr, Dept Diagnost Radiol, Baltimore, MD 21201 USA
[2] Univ Maryland, Med Ctr, Dept Neuroradiol, Baltimore, MD 21201 USA
[3] Univ Maryland, Med Ctr, Dept Neurosurg, Baltimore, MD 21201 USA
关键词
RADIATION-ABSORBING SHIELD; INTERVENTIONAL NEURORADIOLOGY; DOSE REDUCTION; PATIENT; ANGIOGRAPHY; DRAPE; STERILE; TUMORS; BRAIN; RISK;
D O I
10.3174/ajnr.A5038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Neurointerventional surgery may expose patients and physician operators to substantial amounts of ionizing radiation. Although strategies for reducing patient exposure have been explored in the medical literature, there has been relatively little published in regards to decreasing operator exposure. The purpose of this study was to evaluate the efficacy of shielding systems in reducing physician exposure in a modern neurointerventional practice. MATERIALS AND METHODS: Informed consent was obtained from operators for this Health Insurance Portability and Accountability Act-compliant, institutional review board-approved study. Operator radiation exposure was prospectively measured during 60 consecutive neurointerventional procedures from October to November 2013 using a 3-part lead shielding system. Exposure was then evaluated without lead shielding in a second 60-procedure block from April to May 2014. A radiation protection drape was randomly selected for use in half of the cases in each block. Two-way analysis of covariance was performed to test the effect of shielding systems on operator exposure while controlling for other covariates, including procedure dose-area product. RESULTS: Mean operator procedure dose was 20.6 Sv for the entire cohort and 17.7 Sv when using some type of shielding. Operator exposure significantly correlated with procedure dose-area product, but not with other covariates. After we adjusted for procedure dose-area product, the use of lead shielding or a radiation protection drape significantly reduced operator exposure by 45% (F = 12.54, P < .0001) and 29% (F = 7.02, P = .009), respectively. The difference in protection afforded by these systems was not statistically significant (P = .46), and their adjunctive use did not provide additional protection. CONCLUSIONS: Extensive lead shielding should be used as much as possible in neurointerventional surgery to reduce operator radiation exposure to acceptable levels. A radiation protection drape is a reasonable alternative when standard lead shielding is unavailable or impractical to use without neglecting strategies to minimize the dose.
引用
收藏
页码:450 / 454
页数:5
相关论文
共 50 条
  • [21] Efficacy of FLOT regimen in the Polish population e real-world data from a prospective biomarker study
    Marcisz-Grzanka, K.
    Winiarek, M.
    Palucki, J.
    Wieszczy, P.
    Olesinski, T.
    Samsel, R.
    Sulkowska, U.
    Kolasinska-Cwikla, A.
    Jozwiak, M.
    Wyrwicz, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S338 - S339
  • [22] Investigating the efficacy of virtual reality exposure for crowd management: a real-world application
    Alshaer, Abdulaziz
    FRONTIERS IN VIRTUAL REALITY, 2024, 5
  • [23] Efficacy and Safety of Telitacicept in IgA Nephropathy: A Real-World Study
    Dong Lingqiu
    Qin Wei
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Efficacy and safety of telitacicept in IgA nephropathy: a real-world study
    Dong, Lingqiu
    Qin, Wei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [25] Efficacy and safety of telitacicept in IgA nephropathy: a real-world study
    Dong, Lingqiu
    Qin, Wei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I712 - I713
  • [26] Efficacy and safety of telitacicept in IgA nephropathy: a real-world study
    Dong, Lingqiu
    Yang, Dandan
    Qin, Aiya
    Wang, Siqing
    Tang, Yi
    Tan, Jiaxing
    Qin, Wei
    RENAL FAILURE, 2025, 47 (01)
  • [27] Real-World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single-Center Prospective Study
    Li, Zheng
    Wang, Yu
    Wu, Yuemeng
    Yin, Huibin
    Wang, Shangshang
    Wu, Hao
    Qin, Haihong
    Wang, Ce
    Yao, Xu
    Li, Wei
    Gu, Chaoying
    ALLERGY, 2025,
  • [28] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
    Tatsuki Mizuochi
    Itaru Iwama
    Ayano Inui
    Yoshinori Ito
    Yugo Takaki
    Sotaro Mushiake
    Daisuke Tokuhara
    Takashi Ishige
    Koichi Ito
    Jun Murakami
    Haruka Hishiki
    Hitoshi Mikami
    Kazuhiko Bessho
    Ken Kato
    Ryosuke Yasuda
    Yushiro Yamashita
    Yasuhito Tanaka
    Hitoshi Tajiri
    Journal of Gastroenterology, 2023, 58 : 405 - 412
  • [29] Efficacy and Safety of Dabigatran Etexilate and Warfarin in "Real-World" Patients With Atrial Fibrillation A Prospective Nationwide Cohort Study
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Skjoth, Flemming
    Due, Karen Margrete
    Callreus, Torbjorn
    Rosenzweig, Mary
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (22) : 2264 - 2273
  • [30] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
    Mizuochi, Tatsuki
    Iwama, Itaru
    Inui, Ayano
    Ito, Yoshinori
    Takaki, Yugo
    Mushiake, Sotaro
    Tokuhara, Daisuke
    Ishige, Takashi
    Ito, Koichi
    Murakami, Jun
    Hishiki, Haruka
    Mikami, Hitoshi
    Bessho, Kazuhiko
    Kato, Ken
    Yasuda, Ryosuke
    Yamashita, Yushiro
    Tanaka, Yasuhito
    Tajiri, Hitoshi
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (04) : 405 - 412